Our results showing decreased expression levels of P2ry12 during IRI are in line with previous studies investigating CNS disorders such as Alzheimer’s disease [12,13], multiple sclerosis [14], and amyotrophic lateral sclerosis [28]. This evidence concerns the gene P2RY12 and Alzheimer disease.